DNA microarrays: Translation of the genome from laboratory to clinic

Lancet Neurology

Volumn 2, Issue 5, 2003, Pages 275-282

  Geschwind, Daniel H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HALOPERIDOL; PROTEOME;

ALCOHOLISM; AUTISM; BRAIN TUMOR; CANCER; CLINICAL MEDICINE; DNA MICROARRAY; EXPERIMENT; GENE DOSAGE; GENE EXPRESSION; GENE SEQUENCE; GENOME; HUMAN; HUMAN RELATION; KARYOTYPING; LABORATORY; MULTIPLE SCLEROSIS; NERVOUS SYSTEM; NEUROPSYCHIATRY; NONHUMAN; PHARMACOGENOMICS; PRIORITY JOURNAL; REVIEW; RNA TRANSLATION; SCHIZOPHRENIA; SEIZURE; STROKE; CLASSIFICATION; GENETICS; INSTRUMENTATION; MOLECULAR BIOLOGY; NEUROLOGIC DISEASE; PATHOLOGY; PHARMACOGENETICS; PHYSIOLOGY;

ALCOHOLISM; AUTISTIC DISORDER; GENE DOSAGE; GENE EXPRESSION; GENOME; HUMANS; MOLECULAR BIOLOGY; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHARMACOGENETICS; SCHIZOPHRENIA;

EID: 0042011475     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(03)00379-X     Document Type: Review

References (77)

1. Tanzi R.E., Bertram L. New frontiers in Alzheimer's disease genetics. Neuron. 32:2001;181-184.
2. Hardy J. Genetic dissection of primary neurodegenerative diseases. Biochem Soc Symp. 67:2001;51-57.
3. Rosenberg R.N. DNA-triplet repeats and neurologic disease. N Engl J Med. 335:1996;1222-1224.
4. Paulson H.L., Fischbeck K.H. Trinucleotide repeats in neurogenetic disorders. Annu Rev Neurosci. 19:1996;79-107.
5. Venter J.C., Adams M.D., Myers E.W., et al. The sequence of the human genome. Science. 291:2001;1304-1351.
6. Nelson N.J. Draft human genome sequence yields several surprises. J Natl Cancer Inst. 93:2001;493.
7. Geschwind D.H., Gregg J. Microarrays for the Neurosciences. 2002;MIT Press, Cambridge.
8. Sandberg R., Yasuda R., Pankratz D.G., et al. Regional and strain-specific gene expression mapping in the adult mouse brain. Proc Natl Acad Sci USA. 97:2000;11038-11043.
9. Brown V.M., Ossadtchi A., Khan A.H., et al. Gene expression tomography. Physiol Genomics. 8:2002;159-167.
10. Brown V.M., Ossadtchi A., Khan A.H., Cherry S.R., Leahy R.M., Smith D.J. High-throughput imaging of brain gene expression. Genome Res. 12:2002;244-254.
11. Zirlinger M., Kreiman G., Anderson D.J. Amygdala-enriched genes identified by microarray technology are restricted to specific amygdaloid subnuclei. ProcNatl Acad Sci USA. 98:2001;5270-5275.
12. Geschwind D.H., Ou J., Easterday M.C., et al. A genetic analysis of neural progenitor differentiation. Neuron. 29:2001;325-339.
13. Terskikh A.V., Easterday M.C., Li L., et al. From hematopoiesis to neuropoiesis: evidence of overlapping genetic programs. Proc Natl Acad Sci USA. 98:2001;7934-7939.
14. Phillips R.L., Ernst R.E., Brunk B., et al. The genetic program of hematopoietic stem cells. Science. 288:2000;1635-1640.
15. D'Agata V., Warren S.T., Zhao W., Torre E.R., Alkon D.L., Cavallaro S. Gene expression profiles in a transgenic animal model of fragile X syndrome. Neurobiol Dis. 10:2002;211-218.
16. Brown V., Jin P., Ceman S., et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell. 107:2001;477-487.
17. Schena M., Shalon D., Davis R.W., Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 270:1995;467-470.
18. Lipshutz R.J., Fodor S.P., Gingeras T.R., Lockhart D.J. High density synthetic oligonucleotide arrays. Nat Genet. 21:(suppl 1):1999;20-24.
19. Geschwind D.H. Sharing gene expression data: an array of options. Nat Rev Neurosci. 2:2001;435-438.
20. Luo Z., Geschwind D.H. Microarray applications in neuroscience. Neurobiol Dis. 8:2001;183-193.
21. DeRisi J., Penland L., Brown P.O., et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet. 14:1996;457-460.
22. Shalon D., Smith S.J., Brown P.O. A DNA microarray system for analyzing complex DNA samples using two- color fluorescent probe hybridization. Genome Res. 6:1996;639-645.
23. Lockhart D.J., Winzeler E.A. Genomics, gene expression and DNA arrays. Nature. 405:2000;827-836.
24. Whitney L.W., Becker K.G., Tresser N.J., et al. Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays. Ann Neurol. 46:1999;425-428.
25. Chiang L.W., Grenier J.M., Ettwiller L., et al. An orchestrated gene expression component of neuronal programmed cell death revealed by cDNA array analysis. Proc Natl Acad Sci USA. 98:2001;2814-2819.
26. Hughes T.R., Mao M., Jones A.R., et al. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat Biotechnol. 19:2001;342-347.
27. Brenner S., Johnson M., Bridgham J., et al. Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. NatBiotechnol. 18:2000;630-634.
28. Datson N.A., van der Perk J., de Kloet E.R., Vreugdenhil E. Expression profile of 30,000 genes in rat hippocampus using SAGE. Hippocampus. 11:2001;430-444.
29. Velculescu V.E., Vogelstein B., Kinzler K.W. Analysing uncharted transcriptomes with SAGE. Trends Genet. 16:2000;423-425.
30. Velculescu V.E., Zhang L., Vogelstein B., Kinzler K.W. Serial analysis of gene expression. Science. 270:1995;484-487.
31. Karsten SL, Geschwind DH. Gene expression analysis using cDNA microarrays, Curr Protoc Neurosci 2002: Unit 4.25.
32. VanDeerlin V., Ginsberg S.D., Lee V.M., Trojanowski J.Q. The use of fixed human postmortem brain tissue to study mRNA expression in neurodegenerative diseases: applications of microdissection and amplification. Geschwind D.H., Gregg J. Microarrays for the neurosciences: an essential guide. 2002;201-236 MIT Press, Cambridge.
33. Karsten S.L., Van Deerlin V.M., Sabatti C., Gill L.H., Geschwind D.H. An evaluation of tyramide signal amplification and archived fixed and frozen tissue in microarray gene expression analysis. Nucleic Acids Res. 30:2002;E4.
34. Geschwind D.H. Mice, microarrays, and the genetic diversity of the brain. Proc Natl Acad Sci USA. 97:2000;10676-10678.
35. Nadon R., Shoemaker J. Statistical issues with microarrays: processing and analysis. Trends Genet. 18:2002;265-271.
36. Yuen T., Wurmbach E., Pfeffer R.L., Ebersole B.J., Sealfon S.C. Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res. 30:2002;E48.
37. Yue H., Eastman P.S., Wang B.B., et al. An evaluation of the performance of cDNA microarrays for detecting changes in global mRNA expression. Nucleic Acids Res. 29:2001;E41-E41.
38. Kohane I.S., Kho A., Butte A.J. Microarrays for an integrative genomics. 2002;MIT Press, Cambridge.
39. Evans S.J., Datson N.A., Kabbaj M., et al. Evaluation of Affymetrix Gene Chip sensitivity in rat hippocampal tissue using SAGE analysis: serial analysis of gene expression. Eur J Neurosci. 16:2002;409-413.
40. Crino P.B., Trojanowski J.Q., Dichter M.A., Eberwine J. Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology. Proc Natl Acad Sci USA. 93:1996;14152-14157.
41. Eberwine J., Yeh H., Miyashiro K., et al. Analysis of gene expression in single live neurons. Proc Natl Acad Sci USA. 89:1992;3010-3014.
42. Ginsberg S.D., Hemby S.E., Lee V.M., Eberwine J.H., Trojanowski J.Q. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol. 48:2000;77-87.
43. Luo L., Salunga R.C., Guo H., et al. Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat Med. 5:1999;117-122.
44. Bonner R.F., Emmert-Buck M., Cole K., et al. Laser capture microdissection: molecular analysis of tissue. Science. 278:1997;1481-1483.
45. Merikangas K.R., Chakravarti A., Moldin S.O., et al. Future of genetics of mood disorders research. Biol Psychiatry. 52:2002;457-477.
46. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517.
47. Nadeau J.H., Frankel W.N. The roads from phenotypic variation to gene discovery: mutagenesis versus QTLs. Nat Genet. 25:2000;381-384.
48. Frankel W.N. Taking stock of complex trait genetics in mice. Trends Genet. 11:1995;471-477.
49. Lock C., Hermans G., Pedotti R., et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 8:2002;500-508.
50. Hanzel D.K., Trojanowski J.Q., Johnston R.F., Loring J.F. High-throughput quantitative histological analysis of Alzheimer's disease pathology using a confocal digital microscanner. Nat Biotechnol. 17:1999;53-57.
51. Sallinen S.L., Sallinen P.K., Haapasalo H.K., et al. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res. 60:2000;6617-6622.
52. Whitney L.W., Ludwin S.K., McFarland H.F., Biddison W.E. Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J Neuroimmunol. 121:2001;40-48.
53. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 28:2000;53-67.
54. Mirnics K., Middleton F.A., Stanwood G.D., Lewis D.A., Levitt P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry. 6:2001;293-301.
55. Middleton F.A., Mirnics K., Pierri J.N., Lewis D.A., Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci. 22:2002;2718-2729.
56. Hakak Y., Walker J.R., Li C., et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA. 98:2001;4746-4751.
57. Lord C., Volkmar F. Genetics of childhood disorders: XLII, autism, part 1: diagnosis and assessment in autistic spectrum disorders. J Am Acad Child Adolesc Psychiatry. 41:2002;1134-1136.
58. Lord C., Cook E.H., Leventhal B.L., Amaral D.G. Autism spectrum disorders. Neuron. 28:2000;355-363.
59. Purcell A.E., Jeon O.H., Zimmerman A.W., Blue M.E., Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology. 57:2001;1618-1628.
60. Colantuoni C., Jeon O.H., Hyder K., et al. Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. Neurobiol Dis. 8:2001;847-865.
61. Lewohl J.M., Wang L., Miles M.F., Zhang L., Dodd P.R., Harris R.A. Gene expression in human alcoholism: microarray analysis of frontal cortex. Alcohol Clin Exp Res. 24:2000;1873-1882.
62. Mayfield R.D., Lewohl J.M., Dodd P.R., Herlihy A., Liu J., Harris R.A. Patterns of gene expression are altered in the frontal and motor cortices of human alcoholics. J Neurochem. 81:2002;802-813.
63. Tang Y., Lu A., Aronow B.J., Sharp F.R. Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann Neurol. 50:2001;699-707.
64. Rickman D.S., Bobek M.P., Misek D.E., et al. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res. 61:2001;6885-6891.
65. Pomeroy S.L., Tamayo P., Gaasenbeek M., et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 415:2002;436-442.
66. Tanwar M.K., Gilbert M.R., Holland E.C. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res. 62:2002;4364-4368.
67. Geschwind D.H., Gregg J., Boone K., et al. Klinefelter's syndrome as a model of anomalous cerebral laterality: testing gene dosage in the X chromosome pseudoautosomal region using a DNA microarray. Dev Genet. 23:1998;215-229.
68. Varis A., Wolf M., Monni O., et al. Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res. 62:2002;2625-2629.
69. Cai W.W., Mao J.H., Chow C.W., Damani S., Balmain A., Bradley A. Genome-wide detection of chromosomal imbalances in tumors using BAC microarrays. Nat Biotechnol. 20:2002;393-396.
70. O'Hagan R.C., Chang S., Maser R.S., et al. Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell. 2:2002;149-155.
71. Pollack J.R., Sorlie T., Perou C.M., et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA. 99:2002;12963-12968.
72. Cheung V.G., Nowak N., Jang W., et al. Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature. 409:2001;953-958.
73. Hacia J.G., Fan J.B., Ryder O., et al. Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays. Nat Genet. 22:1999;164-167.
74. Dong S., Wang E., Hsie L., Cao Y., Chen X., Gingeras T.R. Flexible use of high-density oligonucleotide arrays for single-nucleotide polymorphism discovery and validation. Genome Res. 11:2001;1418-1424.
75. Garcia C.K., Mues G., Liao Y., et al. Sequence diversity in genes of lipid metabolism. Genome Res. 11:2001;1043-1052.
76. Gilles P.N., Wu D.J., Foster C.B., Dillon P.J., Chanock S.J. Single nucleotide polymorphic discrimination by an electronic dot blot assay on semiconductor microchips. Nat Biotechnol. 17:1999;365-370.
77. Santacroce R., Ratti A., Caroli F., et al. Analysis of clinically relevant single-nucleotide polymorphisms by use of microelectronic array technology. ClinChem. 48:2002;2124-2130.